Aflac Incorporated reported a challenging fourth quarter of 2025, with total revenues declining 9.3% year-over-year to $4.87 billion, falling short of Wall Street expectations. However, the company experienced a positive market response, highlighting a robust annualized return on equity of 19%. Adjusted earnings per share of $1.57 were 8.2% below analysts' estimates, but Aflac remains focused on growth in group benefits and enhancing efficiency through significant investment in technology.
“Aflac Incorporated · is · a leading provider of supplemental health and life insurance · true”
“Aflac Incorporated · is valued at · a market cap of $59.5 billion · true”
“Aflac Incorporated · operates primarily in · the United States and Japan · true”
“Aflac Incorporated · has gained · 9.5% · over the past 52 weeks”
“Aflac Incorporated · is up · 6.5% · on a YTD basis”
“AFL · has outpaced · the SPDR S&P Insurance ETF’s 1.8% uptick · over the past 52 weeks”
“Aflac Incorporated · reported · Q4 2025 results · true”
“Aflac Incorporated · total revenue declined · 9.3% year over year · to $4.9 billion”
“Aflac Incorporated · adjusted earnings decreased · 5.4% · to $818 million”
“Aflac Incorporated · generated · a strong annualized return on equity of 19% · true”
“Aflac Incorporated · is trading above its mean price target of · $109.57 · true”
“Aflac Incorporated · fourth-quarter 2025 adjusted EPS · $1.57 · missed the Zacks Consensus Estimate by 8.2%”